Cytosorbents (CTSO) Current Deferred Revenue (2013 - 2026)
Cytosorbents (CTSO) reported Current Deferred Revenue of $34000.0 for Q1 2026, down 93.77% on a YoY basis from $546028.0 in Q1 2025, and down 81.32% quarter-over-quarter from $182000.0 in Q4 2025.
Cytosorbents (CTSO) Current Deferred Revenue (2013 - 2026) Analysis & Trends
Cytosorbents has reported Current Deferred Revenue for 9 years, with the latest figure at $34000.0 in Q1 2026.
- For the quarter ending Q1 2026, Current Deferred Revenue fell 93.77% year-over-year to $34000.0; the trailing twelve-month figure through Mar 2026 stood at $34000.0 (down 93.77% YoY), and the FY2025 full-year result was $182000.0, down 69.46% from the prior year.
- Current Deferred Revenue for Q1 2026 stood at $34000.0, down from $182000.0 in the prior quarter.
- The five-year high for Current Deferred Revenue was $1.5 million in Q4 2022, with the low at $34000.0 in Q1 2026.
- Historically, Current Deferred Revenue has averaged $627452.6 across 5 years, with a median of $474514.0 in 2025.
- Annual changes were most pronounced in 2023 — Current Deferred Revenue fell 8.96% — and 2026, when it tumbled 93.77%.
- Cytosorbents' Current Deferred Revenue stood at $1.5 million in 2022, then dropped by 8.96% to $1.4 million in 2023, then slumped by 56.84% to $596000.0 in 2024, then plunged by 69.46% to $182000.0 in 2025, then tumbled by 81.32% to $34000.0 in 2026.
- The last three Current Deferred Revenue figures came in at $34000.0 (Q1 2026), $182000.0 (Q4 2025), and $403000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Cytosorbents | 28.80 Mn | 24.00 Mn | 6.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34,000.00 |
| Dec 31, 2025 | 182,000.00 |
| Sep 30, 2025 | 403,000.00 |
| Jun 30, 2025 | 361,000.00 |
| Mar 31, 2025 | 546,028.00 |
| Dec 31, 2024 | 596,000.00 |
| Dec 31, 2023 | 1.38 Mn |
| Dec 31, 2022 | 1.52 Mn |
| Dec 31, 2021 | 1.95 Mn |
| Dec 31, 2020 | 728,351.00 |
| Dec 31, 2014 | 833.00 |
| Sep 30, 2014 | 3,333.00 |
| Jun 30, 2014 | 5,833.00 |
| Mar 31, 2014 | 117,364.00 |
| Dec 31, 2013 | 272,359.00 |
| Sep 30, 2013 | 435,686.00 |